ATLANTA – An Alcon executive explained the company’s plans to separate its medical device and pharmaceutical businesses, during a company-sponsored press conference here at SECO.Richard E. Weisbarth, OD, FAAO, Alcon vice president of professional affairs, detailed the rationale behind the changes that were announced in January.
At OSN New York, Nicole R. Fram , MD, talks about the challenges of malpositioned IOLs in the setting of corneal diseases.
ATHENS, Greece — A study conducted in Schleswig Holstein, the northernmost federal state of Germany, showed lower standards of care for cataract patients in rural areas compared with urban regions, mainly related to poor and often delayed access to ophthalmological services. “In this part of Germany there are only a few cities surrounded by countryside, where medical services are structurally weaker,” Tim Herbst, MBA, said.
Topography-guided PRK followed by corneal collagen cross-linking yielded a significantly greater improvement in vision than cross-linking alone in eyes with progressive keratoconus, a study found.Both procedures yielded similarly stable postoperative o…
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its fourth quarter and year end 2…
ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, a late-stage clinical biopharmaceutical company developing first-in-class drug therapies for the eye, announces that Richard J. Croarkin is joining its Board of Directors.